Atyr Pharma CFO, General Counsel, and CEO sell shares at $0.98/share on 2026-02-04.

Attyr Pharma Inc. has recently disclosed that Jill Marie Broadfoot, the company's Chief Financial Officer, has sold 1,558 shares at a price of $0.98 per share on February 4, 2026. Additionally, General Counsel Nancy Denyes has sold 1,118 shares at the same price on the same date. Furthermore, Director, President, and CEO Sanjay Shukla has sold 3,745 shares at $0.98 per share on February 4, 2026.